{"entity":{"type":"insider","cik":"0001701815","url":"/insider/0001701815","json_url":"/insider/0001701815.json","name":"Aghazadeh Behzad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":15,"first":"2017-11-15","last":"2026-07-28","span_basis":"filed_date"},"name_variants":[{"name":"Aghazadeh Behzad","source":"filing","n_filings":15,"first_seen":"2017-11-15","last_seen":"2026-07-28"}],"transactions":[{"id":5832141,"accession":"0000902664-26-003270","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-26-003270","line_url":"/filing/0000902664-26-003270#line-3","is_derivative":false,"issuer_cik":"0001633313","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001633313","owner_cik":null,"owner_name":"Avoro Ventures LLC; Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Avoro Ventures LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7905.0,"shares_display":"7,905","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":144266.25,"total_display":"144,266.25","total_whole":"144,266","shares_owned_after":3088888.0,"shares_owned_after_display":"3,088,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-28","scope":"insider"},{"id":5832139,"accession":"0000902664-26-003270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-26-003270","line_url":"/filing/0000902664-26-003270","is_derivative":false,"issuer_cik":"0001633313","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001633313","owner_cik":null,"owner_name":"Avoro Ventures LLC; Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Avoro Ventures LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2383333.0,"shares_display":"2,383,333","price_per_share":15.153356664805129,"price_display":"15.15","price_state":"stated","total_value":36115495.0,"total_display":"36,115,495.00","total_whole":"36,115,495","shares_owned_after":3030983.0,"shares_owned_after_display":"3,030,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-28","scope":"insider","n_lines":2},{"id":2330015,"accession":"0000902664-20-001946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-20-001946","line_url":"/filing/0000902664-20-001946#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1750000.0,"shares_display":"1,750,000","price_per_share":28.5,"price_display":"28.50","price_state":"stated","total_value":49875000.0,"total_display":"49,875,000.00","total_whole":"49,875,000","shares_owned_after":26250000.0,"shares_owned_after_display":"26,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-01","filed_date":"2020-05-01","scope":"insider"},{"id":8611808,"accession":"0000902664-19-004538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-004538","line_url":"/filing/0000902664-19-004538#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":35000000.0,"total_display":"35,000,000.00","total_whole":"35,000,000","shares_owned_after":24500000.0,"shares_owned_after_display":"24,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":8024953,"accession":"0000902664-19-003903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-003903","line_url":"/filing/0000902664-19-003903#line-2","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":14.1,"price_display":"14.10","price_state":"stated","total_value":7050000.0,"total_display":"7,050,000.00","total_whole":"7,050,000","shares_owned_after":22500000.0,"shares_owned_after_display":"22,500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-03","filed_date":"2019-10-04","scope":"insider"},{"id":8024950,"accession":"0000902664-19-003903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-003903","line_url":"/filing/0000902664-19-003903#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":13.23,"price_display":"13.23","price_state":"stated","total_value":13230000.0,"total_display":"13,230,000.00","total_whole":"13,230,000","shares_owned_after":22000000.0,"shares_owned_after_display":"22,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-02","filed_date":"2019-10-04","scope":"insider"},{"id":8278651,"accession":"0000902664-19-003156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-003156","line_url":"/filing/0000902664-19-003156#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62500.0,"shares_display":"62,500","price_per_share":101.88,"price_display":"101.88","price_state":"stated","total_value":6367500.0,"total_display":"6,367,500.00","total_whole":"6,367,500","shares_owned_after":3800000.0,"shares_owned_after_display":"3,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-23","filed_date":"2019-07-25","scope":"insider"},{"id":7992405,"accession":"0000902664-19-002892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-19-002892","line_url":"/filing/0000902664-19-002892#line-3","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":13.84,"price_display":"13.84","price_state":"stated","total_value":3460000.0,"total_display":"3,460,000.00","total_whole":"3,460,000","shares_owned_after":21000000.0,"shares_owned_after_display":"21,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-28","filed_date":"2019-06-28","scope":"insider"},{"id":7992403,"accession":"0000902664-19-002892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-002892","line_url":"/filing/0000902664-19-002892#line-2","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":13.68,"price_display":"13.68","price_state":"stated","total_value":4788000.0,"total_display":"4,788,000.00","total_whole":"4,788,000","shares_owned_after":20750000.0,"shares_owned_after_display":"20,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-28","scope":"insider"},{"id":7992401,"accession":"0000902664-19-002892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-002892","line_url":"/filing/0000902664-19-002892#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Avoro Capital Advisors LLC; Aghazadeh Behzad","owner_display_name":"Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":13.25,"price_display":"13.25","price_state":"stated","total_value":5300000.0,"total_display":"5,300,000.00","total_whole":"5,300,000","shares_owned_after":20400000.0,"shares_owned_after_display":"20,400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":8665311,"accession":"0000902664-19-002619","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-19-002619","line_url":"/filing/0000902664-19-002619#line-3","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":12.47,"price_display":"12.47","price_state":"stated","total_value":3117500.0,"total_display":"3,117,500.00","total_whole":"3,117,500","shares_owned_after":20000000.0,"shares_owned_after_display":"20,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-05","scope":"insider"},{"id":8665306,"accession":"0000902664-19-002619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-002619","line_url":"/filing/0000902664-19-002619#line-2","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":6050000.0,"total_display":"6,050,000.00","total_whole":"6,050,000","shares_owned_after":19750000.0,"shares_owned_after_display":"19,750,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-04","filed_date":"2019-06-05","scope":"insider"},{"id":8665303,"accession":"0000902664-19-002619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-002619","line_url":"/filing/0000902664-19-002619#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":785539.0,"shares_display":"785,539","price_per_share":12.19,"price_display":"12.19","price_state":"stated","total_value":9575720.41,"total_display":"9,575,720.41","total_whole":"9,575,720","shares_owned_after":19250000.0,"shares_owned_after_display":"19,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-05","scope":"insider"},{"id":8198255,"accession":"0000902664-19-002373","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-19-002373","line_url":"/filing/0000902664-19-002373#line-3","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":1868750.0,"total_display":"1,868,750.00","total_whole":"1,868,750","shares_owned_after":18464461.0,"shares_owned_after_display":"18,464,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-15","scope":"insider"},{"id":8198251,"accession":"0000902664-19-002373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-002373","line_url":"/filing/0000902664-19-002373#line-2","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":15.4,"price_display":"15.40","price_state":"stated","total_value":1925000.0,"total_display":"1,925,000.00","total_whole":"1,925,000","shares_owned_after":18339461.0,"shares_owned_after_display":"18,339,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-15","scope":"insider"},{"id":8198246,"accession":"0000902664-19-002373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-002373","line_url":"/filing/0000902664-19-002373#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":15.07,"price_display":"15.07","price_state":"stated","total_value":7535000.0,"total_display":"7,535,000.00","total_whole":"7,535,000","shares_owned_after":18214461.0,"shares_owned_after_display":"18,214,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":8024932,"accession":"0000902664-19-001604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-19-001604","line_url":"/filing/0000902664-19-001604#line-3","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23781.0,"shares_display":"23,781","price_per_share":72.8,"price_display":"72.80","price_state":"stated","total_value":1731256.8,"total_display":"1,731,256.80","total_whole":"1,731,257","shares_owned_after":3862500.0,"shares_owned_after_display":"3,862,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-20","scope":"insider"},{"id":8024930,"accession":"0000902664-19-001604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-19-001604","line_url":"/filing/0000902664-19-001604#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":73.43,"price_display":"73.43","price_state":"stated","total_value":7343000.0,"total_display":"7,343,000.00","total_whole":"7,343,000","shares_owned_after":3886281.0,"shares_owned_after_display":"3,886,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-20","scope":"insider"},{"id":8024927,"accession":"0000902664-19-001604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-001604","line_url":"/filing/0000902664-19-001604#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":76.55,"price_display":"76.55","price_state":"stated","total_value":9568750.0,"total_display":"9,568,750.00","total_whole":"9,568,750","shares_owned_after":3986281.0,"shares_owned_after_display":"3,986,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-20","scope":"insider"},{"id":8092010,"accession":"0000902664-19-001248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-19-001248","line_url":"/filing/0000902664-19-001248#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"Aghazadeh Behzad; venBio Select Advisor LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":686820.0,"shares_display":"686,820","price_per_share":73.0,"price_display":"73.00","price_state":"stated","total_value":50137860.0,"total_display":"50,137,860.00","total_whole":"50,137,860","shares_owned_after":4111281.0,"shares_owned_after_display":"4,111,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-21","scope":"insider"},{"id":6817360,"accession":"0000902664-18-002624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-18-002624","line_url":"/filing/0000902664-18-002624#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":23.39,"price_display":"23.39","price_state":"stated","total_value":4678000.0,"total_display":"4,678,000.00","total_whole":"4,678,000","shares_owned_after":17714461.0,"shares_owned_after_display":"17,714,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-19","scope":"insider"},{"id":6090508,"accession":"0000902664-18-002593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-18-002593","line_url":"/filing/0000902664-18-002593#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":null,"owner_name":"Aghazadeh Behzad; venBio Select Advisor LLC","owner_display_name":"Aghazadeh Behzad","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":575000.0,"shares_display":"575,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":13800000.0,"total_display":"13,800,000.00","total_whole":"13,800,000","shares_owned_after":17514461.0,"shares_owned_after_display":"17,514,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-15","scope":"insider"},{"id":6514533,"accession":"0000902664-18-002549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-18-002549","line_url":"/filing/0000902664-18-002549#line-1","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (\"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":38.85,"price_display":"38.85","price_state":"stated","total_value":15540000.0,"total_display":"15,540,000.00","total_whole":"15,540,000","shares_owned_after":4798101.0,"shares_owned_after_display":"4,798,101","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-12","scope":"insider"},{"id":4298718,"accession":"0000902664-17-004377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-17-004377","line_url":"/filing/0000902664-17-004377#line-2","is_derivative":false,"issuer_cik":"0001576263","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001576263","owner_cik":null,"owner_name":"venBio Select Advisor LLC; Aghazadeh Behzad","owner_display_name":"venBio Select Advisor LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share (the \"Common Stock\"","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":650000.0,"shares_display":"650,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":8450000.0,"total_display":"8,450,000.00","total_whole":"8,450,000","shares_owned_after":4360601.0,"shares_owned_after_display":"4,360,601","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-16","filed_date":"2017-11-16","scope":"insider"},{"id":5202627,"accession":"0000902664-17-004365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-17-004365","line_url":"/filing/0000902664-17-004365#line-2","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":"0001701815","owner_name":"Aghazadeh Behzad","owner_display_name":"Aghazadeh Behzad","owner_url":"/insider/0001701815","role":"Director, Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":1919750.0,"total_display":"1,919,750.00","total_whole":"1,919,750","shares_owned_after":16064461.0,"shares_owned_after_display":"16,064,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-15","filed_date":"2017-11-15","scope":"insider"},{"id":5202622,"accession":"0000902664-17-004365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-17-004365","line_url":"/filing/0000902664-17-004365#line-1","is_derivative":false,"issuer_cik":"0000722830","issuer_name":"IMMUNOMEDICS INC","issuer_ticker":"IMMU","issuer_name_source":null,"issuer_url":"/issuer/0000722830","owner_cik":"0001701815","owner_name":"Aghazadeh Behzad","owner_display_name":"Aghazadeh Behzad","owner_url":"/insider/0001701815","role":"Director, Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.01 par value per share (the \"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1150000.0,"shares_display":"1,150,000","price_per_share":10.39,"price_display":"10.39","price_state":"stated","total_value":11948500.0,"total_display":"11,948,500.00","total_whole":"11,948,500","shares_owned_after":15889461.0,"shares_owned_after_display":"15,889,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-14","filed_date":"2017-11-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001853921","name":"Scribe Therapeutics, Inc.","url":"/issuer/0001853921","role":"Director, Ten percent owner, Other","n_filings":1,"first_seen":"2026-07-28","last_seen":"2026-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0000722830","name":"IMMUNOMEDICS INC","url":"/issuer/0000722830","role":"Director, Ten percent owner, Other","n_filings":9,"first_seen":"2017-11-15","last_seen":"2020-05-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":5,"first_seen":"2017-11-16","last_seen":"2019-07-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001701815","retrieved_at":"2026-08-24T05:19:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}